Drug Vial Size Report
Active
- Assistance listing
- 93.685
- Agency
-
Centers for Medicare and Medicaid Services
Department of Health and Human Services
- Grant awards
- 1 $1,022,952 in federal obligations
Program facts
- Assistance type
-
- Project Grant
- Eligible applicants
-
- Private nonprofit institution/organization (includes institutions of higher education and hospitals)
- Small business (less than 500 employees)
- Quasi-public nonprofit institution/organization
- Other private institutions/organizations
- Anyone/general public
- U.S. Territories and possessions
- Individual/Family
- Specialized group (e.g. health professionals, students, veterans)
- Intrastate
- Profit organization
- Treasury account
-
- 75-0511-0-1-551
- More information
Program details come from SAM.gov Assistance Listings. Updated . Grant award figures come from USAspending.gov.
About this program
The Centers for Medicare and Medicaid Services (CMS) administers the Drug Vial Size Report program (CFDA 93.685) to fund a discrete study on the federal healthcare costs, safety, and quality impacts of drug waste resulting from weight-based dosing in single-dose vials. The program has not issued a grant award since September 2019, when CMS obligated $1,022,952.46 to fund a single Project Grant with the National Academies of Sciences, Engineering, and Medicine to conduct the congressionally mandated study.
The program's scope is narrowly defined: the funded research assesses federal cost implications of discarded pharmaceuticals, patient safety risks, storage and shipping concerns, FDA guidance on vial sizing, CDC biopharmaceutical manufacturing guidelines, and related quality factors. The study was designed to consult stakeholders including federal health agencies (FDA, CDC, DOD, IHS, VA), specialty physicians and rural practitioners, patient groups, biopharmaceutical manufacturers, health insurers, and healthcare distributors.
The award structure is exclusively Project Grants; the single recent award obligated approximately one million dollars. CMS is the sole funding agency under this listing. The most recent award was issued in September 2019 with an ultimate completion date of March 2021, meaning the funded study concluded over five years ago and no new grant activity has occurred since.
Eligible applicants include states, local governments, public nonprofit institutions, federally recognized Indian tribal governments, U.S. territories, and individuals or families, though the program structure suggests the primary vehicle is a single-award research contract with the National Academies rather than competitive solicitation to broad applicant pools. No current grant opportunity is open, and the source contains no indication that CMS is planning to reopen solicitation under this listing. The program appears dormant following completion of its statutory mandate.
Objective and description
- Objective
The purpose of the program is to conduct a study that highlights Federal healthcare costs, safety and quality concerns associated with discarded drugs that result from disproportionate vial sizes.
- Description
CMS shall entered an agreement with the Health and Medicine Division of the National Academies of Sciences, Engineering, and Medicine [the Academies] to conduct a study on the Federal healthcare costs, safety, and quality concerns associated with discarded drugs that results from weight-based dosing of medicines contained in single dose vials as stated in Senate report 114-274. As part of this study, the Academies should assess factors such as patient safety; storage/shipping issues; FDA guidance; CDC guidelines to biopharmaceutical manufacturers; and the Federal cost of discarded drugs. Stakeholders, including CMS, FDA, CDC, DOD, IHS, VA, specialty physicians [including rural practitioners], specialty clinics [including rural clinics], patient groups, biopharmaceutical manufacturers, health insurance companies, and healthcare distributors/wholesalers shall be consulted.
Eligibility
- Applicant eligibility
State, Local, Unemployed, Welfare Recipient, Sponsored organization, Low Income, Public nonprofit institution/organization, Other public institution/organization, Federally Recognized Indian Tribal Governments State, Intrastate, Local, Sponsored Organization, Public Nonprofit Institution/Organization, Other Public Institution/organization, Federally Recognized Indian Tribal Government, U.S. territory/possession, individual/family
- Uses of assistance
Funds will be available for services related to a study on the Federal healthcare costs, safety, and quality concerns associated with discarded drugs that results from weight-based dosing of medicines contained in single dose vials as stated in Senate report 114-274.
- Length and time phasing of assistance
Twelve months (1 year) from the date of award with 12 month budget period. Method of awarding/releasing assistance: quarterly
How to apply
- Application procedure
All instructions covered by 2 CFR 200
- Award procedure
If successful, Applicant will receive a Notice of Award (NoA) signed and dated by the HHS Grants Management Officer. The NoA is the document authorizing the grant award and will be issued to the applicant as listed on the SF-424 and available to the organization through the online grants management system used by CMS and awardee organizations. Any communication between HHS and Applicant prior to issuance of the NoA is not an authorization to begin performance of a project. If unsuccessful, Applicant will be notified by letter, sent electronically or through the U.S. Postal Service to the address as listed on its SF-424, within 30 days of the award date.
- Time to approval or disapproval
Approximately 30-45 days
Grant awards
| Award | Recipient | Federal obligations | Awarded |
|---|---|---|---|
| Drug vial size report | National Academy Of Sciences | $1,022,952 |
Top recipients by federal obligations
| Rank | Recipient | Federal obligations | Share |
|---|---|---|---|
| 1 | National Academy Of Sciences | $1,022,952 | 100% |
Federal obligations by fiscal year
| Fiscal year | Federal obligations |
|---|---|
| FY2022 | -$177,048 |
| FY2019 | $1,200,000 |
Quick answers
What is Assistance Listing 93.685?
Assistance Listing 93.685 is Drug Vial Size Report, a federal grant program run by Centers for Medicare and Medicaid Services (Department of Health and Human Services).
What is the CFDA number for Drug Vial Size Report?
Its CFDA number is 93.685: Assistance Listing numbers were called CFDA numbers before 2018.
How much funding has Assistance Listing 93.685 awarded?
1 grant award under 93.685 have obligated $1,022,952 in federal funds to 1 recipient.
Who receives the most funding from 93.685?
The recipients obligated the most under Drug Vial Size Report are National Academy Of Sciences ($1,022,952).
On GovTribe
See this program's full record
- Every grant award and opportunity under it
- Funding by recipient, agency and assistance type
- Alerts for new opportunities
- Ask GovTribe AI about this program